Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for diagnosing...

Imaging Studies II: Ultrasonography

Imaging Studies II: Ultrasonography

IntroductionUltrasonography, or renal ultrasound, is a noninvasive medical imaging technique that uses high-frequency sound waves to visualize the kidneys, ureters, bladder, and surrounding tissues.Indications for Urinary System UltrasonographyUrinary system ultrasonography is indicated in various clinical scenarios, such as:Kidney Stones (Urolithiasis): To detect and monitor the size and presence of kidney or urinary tract stones.Hydronephrosis: To assess the dilation of the renal pelvis and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Healthcare costs of managing MAFLD are mostly driven by hospitalisation and advanced fibrosis: cost-analysis from a tertiary-care, multi-disciplinary MAFLD clinic.

Internal medicine journal·2026

Same author

Reframing neurotrauma research for LSCO: lessons from Ukraine for the UK Defence Medical Services.

BMJ military health·2026

Same author

Influence of MASLD and MAFLD on long-term extrahepatic cancer incidence and cancer mortality in regional Australia.

Internal medicine journal·2026

Same author

Impact of Fatigue on Patient-Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry Study.

Journal of viral hepatitis·2026

Same author

The diagnosis and management of portal hypertension in cirrhosis: The Gastroenterological Society of Australia consensus.

Hepatology communications·2026

Same author

Accelerated impact of alcohol-associated hepatitis on healthcare utilisation during the COVID-19 pandemic.

Internal medicine journal·2026

Search research articles

Related Experiment Video

Updated: May 10, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

FibroScan® and transient elastography.

William Kemp¹, Stuart Roberts

¹Department of Gastroenterology, The Alfred, Melbourne and Monash University Central Clinical School, Melbourne, Victoria, Australia. w.kemp@alfred.org.au

Australian Family Physician

|July 5, 2013

Summary

Transient elastography (TE) is a reliable, non-invasive method for assessing liver scarring in chronic liver disease patients. FibroScan® effectively detects cirrhosis and significant fibrosis when used with clinical data.

Area of Science:

Hepatology
Medical Imaging
Diagnostic Technologies

Background:

Non-invasive tests are crucial for staging liver disease severity (scarring).
Accurate staging of liver scarring provides prognostic information and guides treatment priorities in chronic liver disease management.
Transient elastography (TE) offers a simple, safe, and efficient method for estimating liver scarring.

Observation:

FibroScan® is a widely adopted non-invasive device in Australia utilizing TE to measure liver 'hardness' or stiffness.
TE, when applied in appropriate clinical contexts, demonstrates reliability in identifying cirrhosis.
TE is effective in excluding significant fibrosis, especially when findings are corroborated by clinical and laboratory data.

Findings:

Transient elastography provides a reliable, non-invasive assessment of liver scarring.

More Related Videos

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy

Published on: July 20, 2022

Related Experiment Videos

Last Updated: May 10, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy

Published on: July 20, 2022

FibroScan® device is a popular tool for TE in Australia.

TE aids in detecting cirrhosis and ruling out significant fibrosis.

Implications:

TE can improve patient management by accurately staging liver disease.
Non-invasive methods like TE can reduce the need for invasive procedures.
Integration of TE with clinical data enhances diagnostic accuracy for liver fibrosis and cirrhosis.